ARID5B and cervical carcinoma: The methylation of ARID5B could focus on the specific cell cycle genes of cervical cancer cells and would have minimal side-effects on the shared core genes and thus provide greater therapeutic benefits (Berger and Iyengar, 2009; Zhao and Iyengar, 2012).